HighTower Advisors »

Rigel Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $475k 11k 42.83

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Rigel Pharmaceuticals

BlackRock
State Street Corporation
Vanguard Group
Armistice Capital
Goldman Sachs Group
Marshall Wace
Capitolis Liquid Global Markets
LSV Asset Management
Renaissance Technologies
Acadian Asset Management
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Jane Street
D. E. Shaw & Co
Soleus Capital Management

View all funds holding Rigel Pharmaceuticals